Markets
Hims & Hers Big Game commercial
A screenshot of Hims & Hers’ 2025 Super Bowl commercial (Sherwood News)

Hims slides as Q2 revenue undershoots estimates and falls sequentially for the first time

Still, the telehealth company kept its full-year revenue guidance intact.

J. Edward Moreno

Hims & Hers dropped 9.5% in after-hours trading after the telehealth company reported quarterly revenue that missed Wall Street’s expectations and fell quarter to quarter for the first time.

Hims posted earnings per share of $0.17, higher than the $0.15 analysts polled by FactSet were expecting. But it also reported $544.8 million in revenue, less than the $552 million the Street was penciling in.

Hims kept its full-year revenue guidance of between $2.3 billion and $2.4 billion intact.

Hims announced in June that it had acquired UK-based peer Zava. The company paid $265.7 million for Zava, it disclosed on Monday. In its shareholder letter, it said it expects Zava to contribute $50 million of revenue through the remainder of the year.

The report gave investors a look at how the company was doing in the months leading up to and the weeks after its very public falling out with Novo Nordisk. The stock took a punch when the deal fell through but has since recovered those losses and then some.

The company had to stop selling exact copies of Novo’s Ozempic and Wegovy on May 22. Hims is still selling “personalized” versions of Novo’s blockbuster drugs, which is why Novo abruptly cut off its deal to offer cash-pay versions of its name-brand drug on the telehealth platform on June 23. 

Hims reported that it sold $190 million worth of GLP-1s in the second quarter, compared to $230 million in the first quarter, when it was still allowed to sell exact copies. The company has a goal of making $725 million in revenue from its weight-loss segment, which also includes other drugs besides GLP-1s, this year.

Novo, which reports earnings on Wednesday, also recently cut its guidance, citing competition from compounders like Hims, though its sales are also slumping among insured patients.

More Markets

See all Markets
markets

SpaceX gets a wave of bullish ratings from Wall Street analysts

SpaceX received more than a dozen positive analyst calls on Tuesday — including from major Wall Street banks — as they initiate coverage on Elon Musk’s space and AI company.

SpaceX went public on June 12 at a $2.2 trillion valuation, the largest debut in history. While the company hasn’t yet posted a profit, it seems to have convinced Wall Street that it will get there and grow its valuation on the way.

Of the at least 17 analysts that gave a rating on Tuesday, all but one gave it a “buy” or “outperform” rating. MoffettNathanson was "neutral."

The ratings come as SpaceX joined the Nasdaq 100 index, a benchmark tech-heavy basket of companies that underpins millions of portfolios. The inclusion adds built-in demand for the stock from index funds and ETFs.

Still, SpaceX fell more than 5% on Tuesday amid a broader sell-off, and is currently effectively flat from its opening price of $150 a share.

markets

Nike sinks to lowest level since 2014 after warning of “challenged” sales environment in Q4 report

Did Nike do it?

Investors had a mixed reaction after the global sports apparel company reported its fourth quarter earnings on Tuesday after the bell. Shares initially rose 5% as Nike beat out Wall Street expectations amid a hefty tariff refund bonus. However, the stock then sank to its lowest level since August 2014 in postmarket trading.

Here are the Q4 numbers:

  • Revenue of $11.0 billion (estimate: $10.8 billion).

  • Adjusted earnings per share of $0.20 (estimate: $0.12).

Ahead of this report, Nike warned that results would be flattered by a one-time tariff refund (now estimated at roughly $0.52 per share for the bottom line). That gave the company an extra cushion in snapping its streak of seven quarters of year-over-year profit declines.

Over the past year, the company had been punished by tariffs on imported goods, stagnant consumer spending, and increasing competition from other footwear brands like New Balance, Adidas, and Hoka.

Outgoing CFO Matthew Friend deemed it an “increasingly challenging operating environment, where sell-through remains challenged.”

markets

Rocket Lab deal lifts space stocks

Shares of Rocket Lab are surging after announcing an $8 billion acquisition of satellite communications operator Iridium Communications, helping lift a broader basket of space-related stocks as investors piled back into the sector.

Planet Labs, AST SpaceMobile and Redwire all traded higher alongside Rocket Lab, extending gains in an industry that has drawn enhanced investor attention in recent months in light of the strategic importance that governments place on space and satellite communications infrastructure.

In a presentation, Rocket Lab’s management called the purchase “a shortcut” for its satellite communications business.

Under the terms of the agreement, Iridium shareholders will receive $27 in cash and Rocket Lab stock, valuing Iridium at $54 per share. Backed by a $3.6 billion bridge loan committed by Deutsche Bank and Wells Fargo, Rocket Lab absorbs Iridium’s globally licensed spectrum and an active base of 2.5 million subscribers.

Rocket Lab has also remained one of the most active launch providers in the sector. The company completed its 12th launch of the year last week, maintaining one of the highest launch cadences among commercial space companies.

Today's rally helps offset a brutal stretch for the group. Rocket Lab shares had fallen over 35% over the prior month, while Planet Labs stock was down more than 40% and AST SpaceMobile stock was down around 30% over the same window.

Latest Stories

Sherwood Media, LLC and Chartr Limited produce fresh and unique perspectives on topical financial news and are fully owned subsidiaries of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Money, LLC, Robinhood U.K. Ltd, Robinhood Derivatives, LLC, Robinhood Gold, LLC, Robinhood Asset Management, LLC, Robinhood Credit, Inc., Robinhood Ventures DE, LLC and, where applicable, its managed investment vehicles.